Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/26/2022 | Praxis Precision Medicines, Inc. | PRAX | Grant | Stock Option (Right to Buy) | 22.8k | $8.38 | $190.7k | | 05/26/2022 |
04/26/2022 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 9.9k | $0.00 | $0 | | 04/26/2022 |
04/26/2022 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 28k | $10.15 | $284.2k | | 04/26/2022 |
06/08/2021 | Praxis Precision Medicines, Inc. | PRAX | Grant | Stock Option (Right to Buy) | 22.3k | $20.42 | $456.2k | | 06/08/2021 |
05/13/2021 | Praxis Precision Medicines, Inc. | PRAX | Other (acquisition) | Common Stock | 28.5k | $0.00 | $0 | | 05/13/2021 |
04/27/2021 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $20.35 | $122.1k | | 04/27/2021 |
04/27/2021 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 9.8k | $0.00 | $0 | | 04/27/2021 |
06/01/2020 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Stock Option (Right to Buy) | 4.5k | $286.27 | $1.3M | | 06/01/2020 |
04/28/2020 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 6.6k | $0.00 | $0 | | 04/28/2020 |
04/28/2020 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $30.14 | $180.8k | | 04/28/2020 |
01/02/2020 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Sale | Common Stock | 7.3k | $218.73 | $1.6M | | 01/02/2020 |
01/02/2020 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Sale | Common Stock | 2.5k | $217.72 | $544.3k | | 01/02/2020 |
01/02/2020 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Sale | Common Stock | 10.1k | $219.37 | $2.2M | | 01/02/2020 |
01/02/2020 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Sale | Common Stock | 100 | $220.08 | $22k | | 01/02/2020 |
01/02/2020 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Exercise | Stock Option (Right to Buy) | 20k | $72.14 | $1.4M | | 01/02/2020 |
12/30/2019 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Sale | Common Stock | 7.4k | $218.05 | $1.6M | | 12/30/2019 |
12/30/2019 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Sale | Common Stock | 21.8k | $218.93 | $4.8M | | 12/30/2019 |
12/30/2019 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Sale | Common Stock | 500 | $220.25 | $110.1k | | 12/30/2019 |
12/30/2019 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Sale | Common Stock | 300 | $221.16 | $66.3k | | 12/30/2019 |
12/30/2019 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Exercise | Stock Option (Right to Buy) | 30k | $65.65 | $2M | | 12/30/2019 |
06/01/2019 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Common Stock | 2.4k | $0.00 | $0 | | 06/01/2019 |
04/30/2019 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 8.4k | $0.00 | $0 | | 04/30/2019 |
04/30/2019 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $23.85 | $143.1k | | 04/30/2019 |
06/01/2018 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Common Stock | 1.8k | $0.00 | $0 | | 06/01/2018 |
06/01/2018 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Stock Option (Right to Buy) | 3.2k | $152.74 | $493.2k | | 06/01/2018 |
05/01/2018 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 8.2k | $0.00 | $0 | | 05/01/2018 |
05/01/2018 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $24.43 | $146.6k | | 05/01/2018 |
06/01/2017 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Exercise | Stock Option (Right to Buy) | 5.3k | $125.71 | $665.6k | | 06/01/2017 |
06/01/2017 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Common Stock | 2.2k | $0.00 | $0 | | 06/01/2017 |
05/17/2017 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 6k | $0.00 | $0 | | 05/17/2017 |
06/01/2016 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Stock Option (Right to Buy) | 7.1k | $93.51 | $661.4k | | 06/01/2016 |
06/01/2016 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Grant | Common Stock | 2.9k | $0.01 | $29.4 | | 06/01/2016 |
05/03/2016 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 6k | $0.00 | $0 | | 05/03/2016 |
04/24/2013 | Innoviva, Inc. | INVA | Grant | Stock Option (Right to Buy) | 6k | $30.54 | $183.2k | | 04/24/2013 |
04/24/2013 | Innoviva, Inc. | INVA | Grant | Common Stock | 6k | $0.00 | $0 | | 04/24/2013 |
|